Index by author
December 01, 2006; Volume 34,Issue 12
A
Akao, Teruaki
- You have accessPharmacokinetics of Berberine and Its Main Metabolites in Conventional and Pseudo Germ-Free Rats Determined by Liquid Chromatography/Ion Trap Mass SpectrometryFeng Zuo, Norio Nakamura, Teruaki Akao and Masao HattoriDrug Metabolism and Disposition December 2006, 34 (12) 2064-2072; DOI: https://doi.org/10.1124/dmd.106.011361
Allen, James L.
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Arvidsson, B.
- You have accessCharacterization of Human Urinary Metabolites of the Antimalarial PiperaquineJ. Tarning, Y. Bergqvist, N. P. Day, J. Bergquist, B. Arvidsson, N. J. White, M. Ashton and N. LindegårdhDrug Metabolism and Disposition December 2006, 34 (12) 2011-2019; DOI: https://doi.org/10.1124/dmd.106.011494
Ashton, M.
- You have accessCharacterization of Human Urinary Metabolites of the Antimalarial PiperaquineJ. Tarning, Y. Bergqvist, N. P. Day, J. Bergquist, B. Arvidsson, N. J. White, M. Ashton and N. LindegårdhDrug Metabolism and Disposition December 2006, 34 (12) 2011-2019; DOI: https://doi.org/10.1124/dmd.106.011494
B
Backman, Janne T.
- You have accessRofecoxib Is a Potent, Metabolism-Dependent Inhibitor of CYP1A2: Implications for in Vitro Prediction of Drug InteractionsMarjo J. Karjalainen, Pertti J. Neuvonen and Janne T. BackmanDrug Metabolism and Disposition December 2006, 34 (12) 2091-2096; DOI: https://doi.org/10.1124/dmd.106.011965
Bagnati, R.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Bahadduri, Praveen M.
- You have accessRapid Identification of P-glycoprotein Substrates and InhibitorsCheng Chang, Praveen M. Bahadduri, James E. Polli, Peter W. Swaan and Sean EkinsDrug Metabolism and Disposition December 2006, 34 (12) 1976-1984; DOI: https://doi.org/10.1124/dmd.106.012351
Bergquist, J.
- You have accessCharacterization of Human Urinary Metabolites of the Antimalarial PiperaquineJ. Tarning, Y. Bergqvist, N. P. Day, J. Bergquist, B. Arvidsson, N. J. White, M. Ashton and N. LindegårdhDrug Metabolism and Disposition December 2006, 34 (12) 2011-2019; DOI: https://doi.org/10.1124/dmd.106.011494
Bergqvist, Y.
- You have accessCharacterization of Human Urinary Metabolites of the Antimalarial PiperaquineJ. Tarning, Y. Bergqvist, N. P. Day, J. Bergquist, B. Arvidsson, N. J. White, M. Ashton and N. LindegårdhDrug Metabolism and Disposition December 2006, 34 (12) 2011-2019; DOI: https://doi.org/10.1124/dmd.106.011494
Bertino, Joseph S.
- You have accessDrug-Metabolizing Enzyme Inhibition by Ketoconazole Does Not Reduce Interindividual Variability of CYP3A Activity as Measured by Oral MidazolamMaylee Chen, Anne N. Nafziger and Joseph S. BertinoDrug Metabolism and Disposition December 2006, 34 (12) 2079-2082; DOI: https://doi.org/10.1124/dmd.106.011742
Bihorel, Sébastien
- You have accessInfluence of Hydroxyurea On Imatinib Mesylate (Gleevec) Transport at the Mouse Blood-Brain BarrierSébastien Bihorel, Gian Camenisch, Gerhard Gross, Michel Lemaire and Jean-Michel ScherrmannDrug Metabolism and Disposition December 2006, 34 (12) 1945-1949; DOI: https://doi.org/10.1124/dmd.106.010975
Borbás, Tímea
- You have accessInvestigation of Structure and Function of a Catalytically Efficient Variant of the Human Flavin-Containing Monooxygenase Form 3Tímea Borbás, Jun Zhang, Matt A. Cerny, István Likó and John R. CashmanDrug Metabolism and Disposition December 2006, 34 (12) 1995-2002; DOI: https://doi.org/10.1124/dmd.106.010827
Boykin, David W.
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Bridges, Arlene S.
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
C
Camenisch, Gian
- You have accessInfluence of Hydroxyurea On Imatinib Mesylate (Gleevec) Transport at the Mouse Blood-Brain BarrierSébastien Bihorel, Gian Camenisch, Gerhard Gross, Michel Lemaire and Jean-Michel ScherrmannDrug Metabolism and Disposition December 2006, 34 (12) 1945-1949; DOI: https://doi.org/10.1124/dmd.106.010975
Cashman, John R.
- You have accessInvestigation of Structure and Function of a Catalytically Efficient Variant of the Human Flavin-Containing Monooxygenase Form 3Tímea Borbás, Jun Zhang, Matt A. Cerny, István Likó and John R. CashmanDrug Metabolism and Disposition December 2006, 34 (12) 1995-2002; DOI: https://doi.org/10.1124/dmd.106.010827
Cerny, Matt A.
- You have accessInvestigation of Structure and Function of a Catalytically Efficient Variant of the Human Flavin-Containing Monooxygenase Form 3Tímea Borbás, Jun Zhang, Matt A. Cerny, István Likó and John R. CashmanDrug Metabolism and Disposition December 2006, 34 (12) 1995-2002; DOI: https://doi.org/10.1124/dmd.106.010827
Chang, Cheng
- You have accessRapid Identification of P-glycoprotein Substrates and InhibitorsCheng Chang, Praveen M. Bahadduri, James E. Polli, Peter W. Swaan and Sean EkinsDrug Metabolism and Disposition December 2006, 34 (12) 1976-1984; DOI: https://doi.org/10.1124/dmd.106.012351
Chang, Jae H.
- You have accessThe Role of P-glycoprotein in the Bioactivation of RaloxifeneJae H. Chang, Christopher J. Kochansky and Magang ShouDrug Metabolism and Disposition December 2006, 34 (12) 2073-2078; DOI: https://doi.org/10.1124/dmd.106.012179
Chen, Maylee
- You have accessDrug-Metabolizing Enzyme Inhibition by Ketoconazole Does Not Reduce Interindividual Variability of CYP3A Activity as Measured by Oral MidazolamMaylee Chen, Anne N. Nafziger and Joseph S. BertinoDrug Metabolism and Disposition December 2006, 34 (12) 2079-2082; DOI: https://doi.org/10.1124/dmd.106.011742
Cheung, Yen-Ling
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Collins, Roxane
- You have accessMetabolic Aromatization of N-Alkyl-1,2,3,4-Tetrahydroquinoline Substructures to Quinolinium by Human Liver Microsomes and Horseradish PeroxidaseChungang Gu, Roxane Collins, Daniel D. Holsworth, Gregory S. Walker and Richard L. VoormanDrug Metabolism and Disposition December 2006, 34 (12) 2044-2055; DOI: https://doi.org/10.1124/dmd.106.012286
Colombo, T.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
D
D'Incalci, M.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Day, N. P.
- You have accessCharacterization of Human Urinary Metabolites of the Antimalarial PiperaquineJ. Tarning, Y. Bergqvist, N. P. Day, J. Bergquist, B. Arvidsson, N. J. White, M. Ashton and N. LindegårdhDrug Metabolism and Disposition December 2006, 34 (12) 2011-2019; DOI: https://doi.org/10.1124/dmd.106.011494
Dever, Joseph T.
- You have accessIn Vivo Metabolism of l-Methionine in Mice: Evidence for Stereoselective Formation of Methionine-d-Sulfoxide and Quantitation of Other Major MetabolitesJoseph T. Dever and Adnan A. ElfarraDrug Metabolism and Disposition December 2006, 34 (12) 2036-2043; DOI: https://doi.org/10.1124/dmd.106.012104
E
Ekins, Sean
- You have accessRapid Identification of P-glycoprotein Substrates and InhibitorsCheng Chang, Praveen M. Bahadduri, James E. Polli, Peter W. Swaan and Sean EkinsDrug Metabolism and Disposition December 2006, 34 (12) 1976-1984; DOI: https://doi.org/10.1124/dmd.106.012351
Elfarra, Adnan A.
- You have accessIn Vivo Metabolism of l-Methionine in Mice: Evidence for Stereoselective Formation of Methionine-d-Sulfoxide and Quantitation of Other Major MetabolitesJoseph T. Dever and Adnan A. ElfarraDrug Metabolism and Disposition December 2006, 34 (12) 2036-2043; DOI: https://doi.org/10.1124/dmd.106.012104
Elliot, David J.
- You have accessSulfinpyrazone C-Glucuronidation Is Catalyzed Selectively by Human UDP-Glucuronosyltransferase 1A9Oranun Kerdpin, David J. Elliot, Peter I. Mackenzie and John O. MinersDrug Metabolism and Disposition December 2006, 34 (12) 1950-1953; DOI: https://doi.org/10.1124/dmd.106.012385
F
Falcioni, C.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Ferguson, Stephen S.
- You have accessPhenytoin Induction of the Cyp2c37 Gene Is Mediated by the Constitutive Androstane ReceptorJonathan P. Jackson, Stephen S. Ferguson, Masahiko Negishi and Joyce A. GoldsteinDrug Metabolism and Disposition December 2006, 34 (12) 2003-2010; DOI: https://doi.org/10.1124/dmd.106.012005
Fontana, G.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Frapolli, R.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
G
Ghanayem, Burhan I.
- You have accessComparative Metabolism and Disposition of Trichloroethylene in Cyp2e1–/–and Wild-Type MiceDojung Kim and Burhan I. GhanayemDrug Metabolism and Disposition December 2006, 34 (12) 2020-2027; DOI: https://doi.org/10.1124/dmd.106.010538
Goldstein, Joyce A.
- You have accessPhenytoin Induction of the Cyp2c37 Gene Is Mediated by the Constitutive Androstane ReceptorJonathan P. Jackson, Stephen S. Ferguson, Masahiko Negishi and Joyce A. GoldsteinDrug Metabolism and Disposition December 2006, 34 (12) 2003-2010; DOI: https://doi.org/10.1124/dmd.106.012005
Gorman, Lee A.
- You have accessCYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition ProfilesVikas Kumar, Jan L. Wahlstrom, Dan A. Rock, Chad J. Warren, Lee A. Gorman and Timothy S. TracyDrug Metabolism and Disposition December 2006, 34 (12) 1966-1975; DOI: https://doi.org/10.1124/dmd.106.010926
Gross, Gerhard
- You have accessInfluence of Hydroxyurea On Imatinib Mesylate (Gleevec) Transport at the Mouse Blood-Brain BarrierSébastien Bihorel, Gian Camenisch, Gerhard Gross, Michel Lemaire and Jean-Michel ScherrmannDrug Metabolism and Disposition December 2006, 34 (12) 1945-1949; DOI: https://doi.org/10.1124/dmd.106.010975
Gu, Chungang
- You have accessMetabolic Aromatization of N-Alkyl-1,2,3,4-Tetrahydroquinoline Substructures to Quinolinium by Human Liver Microsomes and Horseradish PeroxidaseChungang Gu, Roxane Collins, Daniel D. Holsworth, Gregory S. Walker and Richard L. VoormanDrug Metabolism and Disposition December 2006, 34 (12) 2044-2055; DOI: https://doi.org/10.1124/dmd.106.012286
H
Hall, James Edwin
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Hall, Michael
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Halpert, James R.
- You have accessEngineering of Cytochrome P450 3A4 for Enhanced Peroxide-Mediated Substrate Oxidation Using Directed Evolution and Site-Directed MutagenesisSantosh Kumar, Hong Liu and James R. HalpertDrug Metabolism and Disposition December 2006, 34 (12) 1958-1965; DOI: https://doi.org/10.1124/dmd.106.012054
Hattori, Masao
- You have accessPharmacokinetics of Berberine and Its Main Metabolites in Conventional and Pseudo Germ-Free Rats Determined by Liquid Chromatography/Ion Trap Mass SpectrometryFeng Zuo, Norio Nakamura, Teruaki Akao and Masao HattoriDrug Metabolism and Disposition December 2006, 34 (12) 2064-2072; DOI: https://doi.org/10.1124/dmd.106.011361
Hines, Ronald N.
- You have accessEpirubicin Glucuronidation and UGT2B7 Developmental ExpressionMatthew J. Zaya, Ronald N. Hines and Jeffrey C. StevensDrug Metabolism and Disposition December 2006, 34 (12) 2097-2101; DOI: https://doi.org/10.1124/dmd.106.011387
Hiramatsu, Remi
- You have accessFunctional Analysis of Mouse and Monkey Multidrug Resistance-Associated Protein 2 (Mrp2)Mizuki Ninomiya, Kousei Ito, Remi Hiramatsu and Toshiharu HorieDrug Metabolism and Disposition December 2006, 34 (12) 2056-2063; DOI: https://doi.org/10.1124/dmd.106.010991
Ho, Chi-Tang
- You have accessPeracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-GallateJoshua D. Lambert, Shengmin Sang, Jungil Hong, Seok-Joo Kwon, Mao-Jung Lee, Chi-Tang Ho and Chung S. YangDrug Metabolism and Disposition December 2006, 34 (12) 2111-2116; DOI: https://doi.org/10.1124/dmd.106.011460
Hoflack, Jean-Christophe
- You have accessComparison of Coumarin-Induced Toxicity between Sandwich-Cultured Primary Rat Hepatocytes and Rats in Vivo: A Toxicogenomics ApproachAnne S. Kienhuis, Heleen M. Wortelboer, Jean-Christophe Hoflack, Edwin J. Moonen, Jos C.S. Kleinjans, Ben van Ommen, Joost H. M. van Delft and Rob H. StierumDrug Metabolism and Disposition December 2006, 34 (12) 2083-2090; DOI: https://doi.org/10.1124/dmd.106.011262
Hollenberg, Paul F.
- You have accessStructure-Activity Relationship and Elucidation of the Determinant Factor(s) Responsible for the Mechanism-Based Inactivation of Cytochrome P450 2B6 by Substituted Phenyl DiaziridinesYoshimasa Kobayashi, Chitra Sridar, Ute M. Kent, Satish G. Puppali, John M. Rimoldi, Haoming Zhang, Lucy Waskell and Paul F. HollenbergDrug Metabolism and Disposition December 2006, 34 (12) 2102-2110; DOI: https://doi.org/10.1124/dmd.106.011452
Holsworth, Daniel D.
- You have accessMetabolic Aromatization of N-Alkyl-1,2,3,4-Tetrahydroquinoline Substructures to Quinolinium by Human Liver Microsomes and Horseradish PeroxidaseChungang Gu, Roxane Collins, Daniel D. Holsworth, Gregory S. Walker and Richard L. VoormanDrug Metabolism and Disposition December 2006, 34 (12) 2044-2055; DOI: https://doi.org/10.1124/dmd.106.012286
Hong, Jungil
- You have accessPeracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-GallateJoshua D. Lambert, Shengmin Sang, Jungil Hong, Seok-Joo Kwon, Mao-Jung Lee, Chi-Tang Ho and Chung S. YangDrug Metabolism and Disposition December 2006, 34 (12) 2111-2116; DOI: https://doi.org/10.1124/dmd.106.011460
Horie, Toshiharu
- You have accessFunctional Analysis of Mouse and Monkey Multidrug Resistance-Associated Protein 2 (Mrp2)Mizuki Ninomiya, Kousei Ito, Remi Hiramatsu and Toshiharu HorieDrug Metabolism and Disposition December 2006, 34 (12) 2056-2063; DOI: https://doi.org/10.1124/dmd.106.010991
I
Ito, Kousei
- You have accessFunctional Analysis of Mouse and Monkey Multidrug Resistance-Associated Protein 2 (Mrp2)Mizuki Ninomiya, Kousei Ito, Remi Hiramatsu and Toshiharu HorieDrug Metabolism and Disposition December 2006, 34 (12) 2056-2063; DOI: https://doi.org/10.1124/dmd.106.010991
J
Jackson, Jonathan P.
- You have accessPhenytoin Induction of the Cyp2c37 Gene Is Mediated by the Constitutive Androstane ReceptorJonathan P. Jackson, Stephen S. Ferguson, Masahiko Negishi and Joyce A. GoldsteinDrug Metabolism and Disposition December 2006, 34 (12) 2003-2010; DOI: https://doi.org/10.1124/dmd.106.012005
K
Karjalainen, Marjo J.
- You have accessRofecoxib Is a Potent, Metabolism-Dependent Inhibitor of CYP1A2: Implications for in Vitro Prediction of Drug InteractionsMarjo J. Karjalainen, Pertti J. Neuvonen and Janne T. BackmanDrug Metabolism and Disposition December 2006, 34 (12) 2091-2096; DOI: https://doi.org/10.1124/dmd.106.011965
Kent, Ute M.
- You have accessStructure-Activity Relationship and Elucidation of the Determinant Factor(s) Responsible for the Mechanism-Based Inactivation of Cytochrome P450 2B6 by Substituted Phenyl DiaziridinesYoshimasa Kobayashi, Chitra Sridar, Ute M. Kent, Satish G. Puppali, John M. Rimoldi, Haoming Zhang, Lucy Waskell and Paul F. HollenbergDrug Metabolism and Disposition December 2006, 34 (12) 2102-2110; DOI: https://doi.org/10.1124/dmd.106.011452
Kerdpin, Oranun
- You have accessSulfinpyrazone C-Glucuronidation Is Catalyzed Selectively by Human UDP-Glucuronosyltransferase 1A9Oranun Kerdpin, David J. Elliot, Peter I. Mackenzie and John O. MinersDrug Metabolism and Disposition December 2006, 34 (12) 1950-1953; DOI: https://doi.org/10.1124/dmd.106.012385
Kienhuis, Anne S.
- You have accessComparison of Coumarin-Induced Toxicity between Sandwich-Cultured Primary Rat Hepatocytes and Rats in Vivo: A Toxicogenomics ApproachAnne S. Kienhuis, Heleen M. Wortelboer, Jean-Christophe Hoflack, Edwin J. Moonen, Jos C.S. Kleinjans, Ben van Ommen, Joost H. M. van Delft and Rob H. StierumDrug Metabolism and Disposition December 2006, 34 (12) 2083-2090; DOI: https://doi.org/10.1124/dmd.106.011262
Kim, Dojung
- You have accessComparative Metabolism and Disposition of Trichloroethylene in Cyp2e1–/–and Wild-Type MiceDojung Kim and Burhan I. GhanayemDrug Metabolism and Disposition December 2006, 34 (12) 2020-2027; DOI: https://doi.org/10.1124/dmd.106.010538
Kleinjans, Jos C.S.
- You have accessComparison of Coumarin-Induced Toxicity between Sandwich-Cultured Primary Rat Hepatocytes and Rats in Vivo: A Toxicogenomics ApproachAnne S. Kienhuis, Heleen M. Wortelboer, Jean-Christophe Hoflack, Edwin J. Moonen, Jos C.S. Kleinjans, Ben van Ommen, Joost H. M. van Delft and Rob H. StierumDrug Metabolism and Disposition December 2006, 34 (12) 2083-2090; DOI: https://doi.org/10.1124/dmd.106.011262
Kobayashi, Yoshimasa
- You have accessStructure-Activity Relationship and Elucidation of the Determinant Factor(s) Responsible for the Mechanism-Based Inactivation of Cytochrome P450 2B6 by Substituted Phenyl DiaziridinesYoshimasa Kobayashi, Chitra Sridar, Ute M. Kent, Satish G. Puppali, John M. Rimoldi, Haoming Zhang, Lucy Waskell and Paul F. HollenbergDrug Metabolism and Disposition December 2006, 34 (12) 2102-2110; DOI: https://doi.org/10.1124/dmd.106.011452
Kochansky, Christopher J.
- You have accessThe Role of P-glycoprotein in the Bioactivation of RaloxifeneJae H. Chang, Christopher J. Kochansky and Magang ShouDrug Metabolism and Disposition December 2006, 34 (12) 2073-2078; DOI: https://doi.org/10.1124/dmd.106.012179
Kumar, Santosh
- You have accessEngineering of Cytochrome P450 3A4 for Enhanced Peroxide-Mediated Substrate Oxidation Using Directed Evolution and Site-Directed MutagenesisSantosh Kumar, Hong Liu and James R. HalpertDrug Metabolism and Disposition December 2006, 34 (12) 1958-1965; DOI: https://doi.org/10.1124/dmd.106.012054
Kumar, Vikas
- You have accessCYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition ProfilesVikas Kumar, Jan L. Wahlstrom, Dan A. Rock, Chad J. Warren, Lee A. Gorman and Timothy S. TracyDrug Metabolism and Disposition December 2006, 34 (12) 1966-1975; DOI: https://doi.org/10.1124/dmd.106.010926
Kwon, Seok-Joo
- You have accessPeracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-GallateJoshua D. Lambert, Shengmin Sang, Jungil Hong, Seok-Joo Kwon, Mao-Jung Lee, Chi-Tang Ho and Chung S. YangDrug Metabolism and Disposition December 2006, 34 (12) 2111-2116; DOI: https://doi.org/10.1124/dmd.106.011460
L
Lambert, Joshua D.
- You have accessPeracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-GallateJoshua D. Lambert, Shengmin Sang, Jungil Hong, Seok-Joo Kwon, Mao-Jung Lee, Chi-Tang Ho and Chung S. YangDrug Metabolism and Disposition December 2006, 34 (12) 2111-2116; DOI: https://doi.org/10.1124/dmd.106.011460
Lee, Mao-Jung
- You have accessPeracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-GallateJoshua D. Lambert, Shengmin Sang, Jungil Hong, Seok-Joo Kwon, Mao-Jung Lee, Chi-Tang Ho and Chung S. YangDrug Metabolism and Disposition December 2006, 34 (12) 2111-2116; DOI: https://doi.org/10.1124/dmd.106.011460
Lemaire, Michel
- You have accessInfluence of Hydroxyurea On Imatinib Mesylate (Gleevec) Transport at the Mouse Blood-Brain BarrierSébastien Bihorel, Gian Camenisch, Gerhard Gross, Michel Lemaire and Jean-Michel ScherrmannDrug Metabolism and Disposition December 2006, 34 (12) 1945-1949; DOI: https://doi.org/10.1124/dmd.106.010975
Likó, István
- You have accessInvestigation of Structure and Function of a Catalytically Efficient Variant of the Human Flavin-Containing Monooxygenase Form 3Tímea Borbás, Jun Zhang, Matt A. Cerny, István Likó and John R. CashmanDrug Metabolism and Disposition December 2006, 34 (12) 1995-2002; DOI: https://doi.org/10.1124/dmd.106.010827
Lindegårdh, N.
- You have accessCharacterization of Human Urinary Metabolites of the Antimalarial PiperaquineJ. Tarning, Y. Bergqvist, N. P. Day, J. Bergquist, B. Arvidsson, N. J. White, M. Ashton and N. LindegårdhDrug Metabolism and Disposition December 2006, 34 (12) 2011-2019; DOI: https://doi.org/10.1124/dmd.106.011494
Liu, Hong
- You have accessEngineering of Cytochrome P450 3A4 for Enhanced Peroxide-Mediated Substrate Oxidation Using Directed Evolution and Site-Directed MutagenesisSantosh Kumar, Hong Liu and James R. HalpertDrug Metabolism and Disposition December 2006, 34 (12) 1958-1965; DOI: https://doi.org/10.1124/dmd.106.012054
Locuson, Charles W.
- You have accessIdentification of Binding Sites of Non-I-Helix Water Molecules in Mammalian Cytochromes P450Charles W. Locuson and Timothy S. TracyDrug Metabolism and Disposition December 2006, 34 (12) 1954-1957; DOI: https://doi.org/10.1124/dmd.106.011890
Loewen, Greg
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
M
Mackenzie, Peter I.
- You have accessSulfinpyrazone C-Glucuronidation Is Catalyzed Selectively by Human UDP-Glucuronosyltransferase 1A9Oranun Kerdpin, David J. Elliot, Peter I. Mackenzie and John O. MinersDrug Metabolism and Disposition December 2006, 34 (12) 1950-1953; DOI: https://doi.org/10.1124/dmd.106.012385
Manzotti, C.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Marangon, E.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Miners, John O.
- You have accessSulfinpyrazone C-Glucuronidation Is Catalyzed Selectively by Human UDP-Glucuronosyltransferase 1A9Oranun Kerdpin, David J. Elliot, Peter I. Mackenzie and John O. MinersDrug Metabolism and Disposition December 2006, 34 (12) 1950-1953; DOI: https://doi.org/10.1124/dmd.106.012385
Moonen, Edwin J.
- You have accessComparison of Coumarin-Induced Toxicity between Sandwich-Cultured Primary Rat Hepatocytes and Rats in Vivo: A Toxicogenomics ApproachAnne S. Kienhuis, Heleen M. Wortelboer, Jean-Christophe Hoflack, Edwin J. Moonen, Jos C.S. Kleinjans, Ben van Ommen, Joost H. M. van Delft and Rob H. StierumDrug Metabolism and Disposition December 2006, 34 (12) 2083-2090; DOI: https://doi.org/10.1124/dmd.106.011262
Morazzoni, P.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
N
Nafziger, Anne N.
- You have accessDrug-Metabolizing Enzyme Inhibition by Ketoconazole Does Not Reduce Interindividual Variability of CYP3A Activity as Measured by Oral MidazolamMaylee Chen, Anne N. Nafziger and Joseph S. BertinoDrug Metabolism and Disposition December 2006, 34 (12) 2079-2082; DOI: https://doi.org/10.1124/dmd.106.011742
Nakamura, Norio
- You have accessPharmacokinetics of Berberine and Its Main Metabolites in Conventional and Pseudo Germ-Free Rats Determined by Liquid Chromatography/Ion Trap Mass SpectrometryFeng Zuo, Norio Nakamura, Teruaki Akao and Masao HattoriDrug Metabolism and Disposition December 2006, 34 (12) 2064-2072; DOI: https://doi.org/10.1124/dmd.106.011361
Negishi, Masahiko
- You have accessPhenytoin Induction of the Cyp2c37 Gene Is Mediated by the Constitutive Androstane ReceptorJonathan P. Jackson, Stephen S. Ferguson, Masahiko Negishi and Joyce A. GoldsteinDrug Metabolism and Disposition December 2006, 34 (12) 2003-2010; DOI: https://doi.org/10.1124/dmd.106.012005
Neuvonen, Pertti J.
- You have accessRofecoxib Is a Potent, Metabolism-Dependent Inhibitor of CYP1A2: Implications for in Vitro Prediction of Drug InteractionsMarjo J. Karjalainen, Pertti J. Neuvonen and Janne T. BackmanDrug Metabolism and Disposition December 2006, 34 (12) 2091-2096; DOI: https://doi.org/10.1124/dmd.106.011965
Ninomiya, Mizuki
- You have accessFunctional Analysis of Mouse and Monkey Multidrug Resistance-Associated Protein 2 (Mrp2)Mizuki Ninomiya, Kousei Ito, Remi Hiramatsu and Toshiharu HorieDrug Metabolism and Disposition December 2006, 34 (12) 2056-2063; DOI: https://doi.org/10.1124/dmd.106.010991
P
Paine, Mary F.
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Parkinson, Andrew
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Parkinson, Oliver T.
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Polli, James E.
- You have accessRapid Identification of P-glycoprotein Substrates and InhibitorsCheng Chang, Praveen M. Bahadduri, James E. Polli, Peter W. Swaan and Sean EkinsDrug Metabolism and Disposition December 2006, 34 (12) 1976-1984; DOI: https://doi.org/10.1124/dmd.106.012351
Puppali, Satish G.
- You have accessStructure-Activity Relationship and Elucidation of the Determinant Factor(s) Responsible for the Mechanism-Based Inactivation of Cytochrome P450 2B6 by Substituted Phenyl DiaziridinesYoshimasa Kobayashi, Chitra Sridar, Ute M. Kent, Satish G. Puppali, John M. Rimoldi, Haoming Zhang, Lucy Waskell and Paul F. HollenbergDrug Metabolism and Disposition December 2006, 34 (12) 2102-2110; DOI: https://doi.org/10.1124/dmd.106.011452
R
Rimoldi, John M.
- You have accessStructure-Activity Relationship and Elucidation of the Determinant Factor(s) Responsible for the Mechanism-Based Inactivation of Cytochrome P450 2B6 by Substituted Phenyl DiaziridinesYoshimasa Kobayashi, Chitra Sridar, Ute M. Kent, Satish G. Puppali, John M. Rimoldi, Haoming Zhang, Lucy Waskell and Paul F. HollenbergDrug Metabolism and Disposition December 2006, 34 (12) 2102-2110; DOI: https://doi.org/10.1124/dmd.106.011452
Rock, Dan A.
- You have accessCYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition ProfilesVikas Kumar, Jan L. Wahlstrom, Dan A. Rock, Chad J. Warren, Lee A. Gorman and Timothy S. TracyDrug Metabolism and Disposition December 2006, 34 (12) 1966-1975; DOI: https://doi.org/10.1124/dmd.106.010926
S
Sang, Shengmin
- You have accessPeracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-GallateJoshua D. Lambert, Shengmin Sang, Jungil Hong, Seok-Joo Kwon, Mao-Jung Lee, Chi-Tang Ho and Chung S. YangDrug Metabolism and Disposition December 2006, 34 (12) 2111-2116; DOI: https://doi.org/10.1124/dmd.106.011460
Saulter, Janelle Y.
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Scherrmann, Jean-Michel
- You have accessInfluence of Hydroxyurea On Imatinib Mesylate (Gleevec) Transport at the Mouse Blood-Brain BarrierSébastien Bihorel, Gian Camenisch, Gerhard Gross, Michel Lemaire and Jean-Michel ScherrmannDrug Metabolism and Disposition December 2006, 34 (12) 1945-1949; DOI: https://doi.org/10.1124/dmd.106.010975
Shou, Magang
- You have accessThe Role of P-glycoprotein in the Bioactivation of RaloxifeneJae H. Chang, Christopher J. Kochansky and Magang ShouDrug Metabolism and Disposition December 2006, 34 (12) 2073-2078; DOI: https://doi.org/10.1124/dmd.106.012179
Simone, M.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Sridar, Chitra
- You have accessStructure-Activity Relationship and Elucidation of the Determinant Factor(s) Responsible for the Mechanism-Based Inactivation of Cytochrome P450 2B6 by Substituted Phenyl DiaziridinesYoshimasa Kobayashi, Chitra Sridar, Ute M. Kent, Satish G. Puppali, John M. Rimoldi, Haoming Zhang, Lucy Waskell and Paul F. HollenbergDrug Metabolism and Disposition December 2006, 34 (12) 2102-2110; DOI: https://doi.org/10.1124/dmd.106.011452
Stephens, Chad E.
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Stevens, Jeffrey C.
- You have accessEpirubicin Glucuronidation and UGT2B7 Developmental ExpressionMatthew J. Zaya, Ronald N. Hines and Jeffrey C. StevensDrug Metabolism and Disposition December 2006, 34 (12) 2097-2101; DOI: https://doi.org/10.1124/dmd.106.011387
Stierum, Rob H.
- You have accessComparison of Coumarin-Induced Toxicity between Sandwich-Cultured Primary Rat Hepatocytes and Rats in Vivo: A Toxicogenomics ApproachAnne S. Kienhuis, Heleen M. Wortelboer, Jean-Christophe Hoflack, Edwin J. Moonen, Jos C.S. Kleinjans, Ben van Ommen, Joost H. M. van Delft and Rob H. StierumDrug Metabolism and Disposition December 2006, 34 (12) 2083-2090; DOI: https://doi.org/10.1124/dmd.106.011262
Swaan, Peter W.
- You have accessRapid Identification of P-glycoprotein Substrates and InhibitorsCheng Chang, Praveen M. Bahadduri, James E. Polli, Peter W. Swaan and Sean EkinsDrug Metabolism and Disposition December 2006, 34 (12) 1976-1984; DOI: https://doi.org/10.1124/dmd.106.012351
T
Tarning, J.
- You have accessCharacterization of Human Urinary Metabolites of the Antimalarial PiperaquineJ. Tarning, Y. Bergqvist, N. P. Day, J. Bergquist, B. Arvidsson, N. J. White, M. Ashton and N. LindegårdhDrug Metabolism and Disposition December 2006, 34 (12) 2011-2019; DOI: https://doi.org/10.1124/dmd.106.011494
Tidwell, Richard R.
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Tracy, Timothy S.
- You have accessIdentification of Binding Sites of Non-I-Helix Water Molecules in Mammalian Cytochromes P450Charles W. Locuson and Timothy S. TracyDrug Metabolism and Disposition December 2006, 34 (12) 1954-1957; DOI: https://doi.org/10.1124/dmd.106.011890
- You have accessCYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition ProfilesVikas Kumar, Jan L. Wahlstrom, Dan A. Rock, Chad J. Warren, Lee A. Gorman and Timothy S. TracyDrug Metabolism and Disposition December 2006, 34 (12) 1966-1975; DOI: https://doi.org/10.1124/dmd.106.010926
U
Usuki, Etsuko
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
V
van Delft, Joost H. M.
- You have accessComparison of Coumarin-Induced Toxicity between Sandwich-Cultured Primary Rat Hepatocytes and Rats in Vivo: A Toxicogenomics ApproachAnne S. Kienhuis, Heleen M. Wortelboer, Jean-Christophe Hoflack, Edwin J. Moonen, Jos C.S. Kleinjans, Ben van Ommen, Joost H. M. van Delft and Rob H. StierumDrug Metabolism and Disposition December 2006, 34 (12) 2083-2090; DOI: https://doi.org/10.1124/dmd.106.011262
van Ommen, Ben
- You have accessComparison of Coumarin-Induced Toxicity between Sandwich-Cultured Primary Rat Hepatocytes and Rats in Vivo: A Toxicogenomics ApproachAnne S. Kienhuis, Heleen M. Wortelboer, Jean-Christophe Hoflack, Edwin J. Moonen, Jos C.S. Kleinjans, Ben van Ommen, Joost H. M. van Delft and Rob H. StierumDrug Metabolism and Disposition December 2006, 34 (12) 2083-2090; DOI: https://doi.org/10.1124/dmd.106.011262
Voorman, Richard L.
- You have accessMetabolic Aromatization of N-Alkyl-1,2,3,4-Tetrahydroquinoline Substructures to Quinolinium by Human Liver Microsomes and Horseradish PeroxidaseChungang Gu, Roxane Collins, Daniel D. Holsworth, Gregory S. Walker and Richard L. VoormanDrug Metabolism and Disposition December 2006, 34 (12) 2044-2055; DOI: https://doi.org/10.1124/dmd.106.012286
W
Wahlstrom, Jan L.
- You have accessCYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition ProfilesVikas Kumar, Jan L. Wahlstrom, Dan A. Rock, Chad J. Warren, Lee A. Gorman and Timothy S. TracyDrug Metabolism and Disposition December 2006, 34 (12) 1966-1975; DOI: https://doi.org/10.1124/dmd.106.010926
Walker, Gregory S.
- You have accessMetabolic Aromatization of N-Alkyl-1,2,3,4-Tetrahydroquinoline Substructures to Quinolinium by Human Liver Microsomes and Horseradish PeroxidaseChungang Gu, Roxane Collins, Daniel D. Holsworth, Gregory S. Walker and Richard L. VoormanDrug Metabolism and Disposition December 2006, 34 (12) 2044-2055; DOI: https://doi.org/10.1124/dmd.106.012286
Wang, Michael Zhuo
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Warren, Chad J.
- You have accessCYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition ProfilesVikas Kumar, Jan L. Wahlstrom, Dan A. Rock, Chad J. Warren, Lee A. Gorman and Timothy S. TracyDrug Metabolism and Disposition December 2006, 34 (12) 1966-1975; DOI: https://doi.org/10.1124/dmd.106.010926
Waskell, Lucy
- You have accessStructure-Activity Relationship and Elucidation of the Determinant Factor(s) Responsible for the Mechanism-Based Inactivation of Cytochrome P450 2B6 by Substituted Phenyl DiaziridinesYoshimasa Kobayashi, Chitra Sridar, Ute M. Kent, Satish G. Puppali, John M. Rimoldi, Haoming Zhang, Lucy Waskell and Paul F. HollenbergDrug Metabolism and Disposition December 2006, 34 (12) 2102-2110; DOI: https://doi.org/10.1124/dmd.106.011452
White, N. J.
- You have accessCharacterization of Human Urinary Metabolites of the Antimalarial PiperaquineJ. Tarning, Y. Bergqvist, N. P. Day, J. Bergquist, B. Arvidsson, N. J. White, M. Ashton and N. LindegårdhDrug Metabolism and Disposition December 2006, 34 (12) 2011-2019; DOI: https://doi.org/10.1124/dmd.106.011494
Wortelboer, Heleen M.
- You have accessComparison of Coumarin-Induced Toxicity between Sandwich-Cultured Primary Rat Hepatocytes and Rats in Vivo: A Toxicogenomics ApproachAnne S. Kienhuis, Heleen M. Wortelboer, Jean-Christophe Hoflack, Edwin J. Moonen, Jos C.S. Kleinjans, Ben van Ommen, Joost H. M. van Delft and Rob H. StierumDrug Metabolism and Disposition December 2006, 34 (12) 2083-2090; DOI: https://doi.org/10.1124/dmd.106.011262
Y
Yang, Chung S.
- You have accessPeracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-GallateJoshua D. Lambert, Shengmin Sang, Jungil Hong, Seok-Joo Kwon, Mao-Jung Lee, Chi-Tang Ho and Chung S. YangDrug Metabolism and Disposition December 2006, 34 (12) 2111-2116; DOI: https://doi.org/10.1124/dmd.106.011460
Z
Zaffaroni, M.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Zaya, Matthew J.
- You have accessEpirubicin Glucuronidation and UGT2B7 Developmental ExpressionMatthew J. Zaya, Ronald N. Hines and Jeffrey C. StevensDrug Metabolism and Disposition December 2006, 34 (12) 2097-2101; DOI: https://doi.org/10.1124/dmd.106.011387
Zeldin, Darryl C.
- You have accessCYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]Michael Zhuo Wang, Janelle Y. Saulter, Etsuko Usuki, Yen-Ling Cheung, Michael Hall, Arlene S. Bridges, Greg Loewen, Oliver T. Parkinson, Chad E. Stephens, James L. Allen, Darryl C. Zeldin, David W. Boykin, Richard R. Tidwell, Andrew Parkinson, Mary F. Paine and James Edwin HallDrug Metabolism and Disposition December 2006, 34 (12) 1985-1994; DOI: https://doi.org/10.1124/dmd.106.010587
Zhang, Haoming
- You have accessStructure-Activity Relationship and Elucidation of the Determinant Factor(s) Responsible for the Mechanism-Based Inactivation of Cytochrome P450 2B6 by Substituted Phenyl DiaziridinesYoshimasa Kobayashi, Chitra Sridar, Ute M. Kent, Satish G. Puppali, John M. Rimoldi, Haoming Zhang, Lucy Waskell and Paul F. HollenbergDrug Metabolism and Disposition December 2006, 34 (12) 2102-2110; DOI: https://doi.org/10.1124/dmd.106.011452
Zhang, Jun
- You have accessInvestigation of Structure and Function of a Catalytically Efficient Variant of the Human Flavin-Containing Monooxygenase Form 3Tímea Borbás, Jun Zhang, Matt A. Cerny, István Likó and John R. CashmanDrug Metabolism and Disposition December 2006, 34 (12) 1995-2002; DOI: https://doi.org/10.1124/dmd.106.010827
Zucchetti, M.
- You have accessPharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant TumorsR. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. ZucchettiDrug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Zuo, Feng
- You have accessPharmacokinetics of Berberine and Its Main Metabolites in Conventional and Pseudo Germ-Free Rats Determined by Liquid Chromatography/Ion Trap Mass SpectrometryFeng Zuo, Norio Nakamura, Teruaki Akao and Masao HattoriDrug Metabolism and Disposition December 2006, 34 (12) 2064-2072; DOI: https://doi.org/10.1124/dmd.106.011361
In this issue
Advertisement